Brez internetne povezave — prikazana je shranjena različica strani.

Grifols S.A

USUSD
← Na Filter Delnic

Grifols S.A (LSE:0RDU) — Drug Manufacturers - General. Število borz, na katerih se trgujejo delnice družbe: 4. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

⚠ Ne zamenjujte: obstaja še eno podjetje z enakim ali zelo podobnim imenom. To je ločen zapis — preverite ticker, borzo in registrsko številko.
  • Grifols SA — GRF-P · MC ES Registrska številka ni znana

O Podjetju

Spletna Stran
grifols.com
Odnosi z Vlagatelji
grifols.com/en/investors
Sektor
Healthcare · Drug Manufacturers - General
Sedež
NEW YORK, Spain
Izvršni Direktor
Jose Ignacio Abia Buenache
Zaposleni
25 258
Ustanovljena
1909
Na Borzi od
23.11.2007 (LSE:0RDU)
Delnice v Obtoku
422.36 mio.
Prosto Prenosljive Delnice
418.2 mio.
Tržna Kapitalizacija
7.57 mrd. USD
Notranje Osebe
31.19%
Institucionalni Vlagatelji
37.75%
Panoga (SIC)
Pharmaceutical Preparations
Pravna Oblika
5RDO
ISIN
ES0171996012
LEI
959800HSSNXWRKBK4N60
Delež Izplačila
≈7.7%
FCF
641 mio. EUR
Izplačilo / FCF
5%
Dolg
8.52 mrd. EUR
11 let FCF
Dividendni Staž
1 let
Dobički, FCF in izplačane dividende — za 12 mesecev do 30.06.2026 (najnovejše poročilo podjetja).
Opis

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.

oglas

Borze in Oznake

BorzaOznakaValutaCenaVrsta
US USA StocksGIFLF OTCUSD10.547 -5.24%navadne delnice
LSE London Stock Exchange0RDU IOBEUR16.125 +0.00%navadne delnice
MC Bolsa de MadridGRF glavnaEUR9.8 +1.43%navadne delnice
VI Vienna Stock ExchangeGRF dodatnaEUR9.962 +0.99%navadne delnice

Cena v 3 Mesecih

dan rasti dan padca ex-dividendni datum datum izplačilaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Dividende

Grifols S.A (GIFLF) izplačuje dividende enkrat letno.

Ex-DatumIzplačiloZnesek%VrstaOznaka
2026-07-012026-07-020.0824 EUR0.9 %posebnoUS:GIFLF
2025-08-122025-08-130.1500 EUR1.2 %posebnoUS:GIFLF

Največji Imetniki

ImetnikDeležDelniceDatum Poročila
VANGUARD STAR FUNDS-Vang…1%4.28 mio.2026-04-30
VANGUARD TAX-MANAGED FUN…0.66%2.8 mio.2026-06-30
iShares Trust-iShares Co…0.49%2.08 mio.2026-07-31
DFA INVESTMENT DIMENSION…0.34%1.46 mio.2026-04-30
Dimensional ETF Trust-Di…0.25%1.07 mio.2026-04-30
iShares Trust-iShares MS…0.22%935 1282026-07-31
DFA INVESTMENT TRUST CO-…0.17%741 7722026-04-30
VANGUARD Intl Eqy. INDEX…0.16%696 5102026-04-30
SCHWAB STRATEGIC TRUST-S…0.16%676 4822026-05-31
VANGUARD Intl Eqy. INDEX…0.15%634 2982026-04-30
Pacer Advisors, Inc.0%1 3232026-06-30